Publications

Our Research

The Cancer Glycocode as a Family of Diagnostic Biomarkers, Exemplified by Tumor-Associated Gangliosides

Frontiers in Oncology

Abstract: GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of ovarian cancer

2023 American Society of Clinical Oncology (ASCO) meeting

GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of epithelial ovarian cancer

Frontiers in Oncology

Poster Presentation: GD2 and GD3 tumor gangliosides as diagnostic markers for all subtypes and stages of ovarian cancer (OC) in liquid biopsies

2023 Society of Gynecologic Oncology Annual Meeting on Women's Cancer

Tumor Glycolipids, a New Frontier for Early Detection and Precision Medicine in Ovarian Cancer and Other Malignancies

The Journal of Precision Medicine

GD2 and GD3 tumor gangliosides as diagnostic markers for all subtypes and stages of ovarian cancer (OC) in liquid biopsies

2022 Early Detection of Cancer Conference

Aiming for the Sweet Spot: Glyco-Immune Checkpoints and gd T Cells in Targeted Immunotherapy

Frontiers in Immunology